ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Jefferies Healthcare Conference

Author's Avatar
May 24, 2023

ImmunoGen%2C+Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Mark Enyedy, President and CEO, and Anna Berkenblit, Chief Medical Officer, will participate in a fireside chat at the upcoming Jefferies Healthcare Conference in New York, NY. The presentation is scheduled for June 7, 2023 at 9:00 am ET.